128 related articles for article (PubMed ID: 5403806)
1. [Gynecomastia in the uremic patient undergoing periodic hemodialytic treatment].
Sodi A; Rizzo M; Somigli M
Minerva Nefrol; 1969; 16(6):420-4. PubMed ID: 5403806
[No Abstract] [Full Text] [Related]
2. [Quinbolone in the therapy of anemia in uremic patients during periodic hemodialytic treatment].
Amato M; Bigioli F; Beconi D; Martinelli F; Lapini V; Salvadori M
Clin Ter; 1980 Jul; 94(1):57-65. PubMed ID: 7438723
[No Abstract] [Full Text] [Related]
3. [Study of plasma renin activity in uremic patients undergoing periodic hemodialytic treatment].
Pigliucci GM; Suraci V; Alcini E
Chir Patol Sper; 1974 Apr; 22(2):89-97. PubMed ID: 4434788
[No Abstract] [Full Text] [Related]
4. [Changes in prolactin in uremic patients under periodic hemodialytic treatment].
Gasparotto ML; Serafini E; Naso A; Bertoli M; Rebeschini M; Di Landro D; Ruffatti A; Romagnoli GF; Mastrogiacomo I
Minerva Nefrol; 1982; 29(2):101-4. PubMed ID: 7133538
[No Abstract] [Full Text] [Related]
5. [Cholesterol-HDL and apoprotein A in a group of chronic uremic patients undergoing continuing hemodialytic treatment].
Bergesio F; Ciuti R; Manfredi M; Frizzi V; Zerboni R
Minerva Nefrol; 1983; 30(3):165-73. PubMed ID: 6646491
[No Abstract] [Full Text] [Related]
6. Influence of erythropoietin treatment on endocrine abnormalities in haemodialyzed patients.
Kokot F; Wiecek A; Grzeszczak W; Klepacka J; Klin M; Lao M
Contrib Nephrol; 1989; 76():257-70; discussion 270-2. PubMed ID: 2582782
[No Abstract] [Full Text] [Related]
7. [The visual apparatus in the chronic uremic patient during periodic hemodialytic treatment. II. Changes in ocular refraction during hemodialysis].
Ambrosio A; Sorice PS; Tufano L; Tonna G; Esposito E
Rass Int Clin Ter; 1971 Jul; 51(13):789-95. PubMed ID: 5568452
[No Abstract] [Full Text] [Related]
8. [Aspects of carbohydrate metabolism in chronic uremic patients treated with periodic hemodialysis].
Redaelli B; Salvadeo A; Ponticelli C; Imbasciati E; Graziani G
Minerva Nefrol; 1967; 14(4):158-62. PubMed ID: 5607555
[No Abstract] [Full Text] [Related]
9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
10. [Value of the determination of alkaline phosphatase isoenzymes in patients undergoing periodic hemodialytic treatment].
Stefoni S; Campieri C; Bugiardini R; Biagetti L; Perini L
Minerva Nefrol; 1979; 26(2):173-6. PubMed ID: 471344
[No Abstract] [Full Text] [Related]
11. [Oxalate behavior in patients undergoing periodic hemodialytic treatments].
Zucchelli P; Fusaroli M; Sasdelli M; Stallone C
Minerva Nefrol; 1970; 17(6):184-6. PubMed ID: 5516052
[No Abstract] [Full Text] [Related]
12. [The nature of renal lesions and periodic hemodialysis].
Bonomini V; Mioli V; Albertazzi A; Vangelista A
Minerva Nefrol; 1972; 19(2):50-9. PubMed ID: 4681261
[No Abstract] [Full Text] [Related]
13. [Polycentric analysis of the behavior of uremic patients undergoing dialysis].
Figus S; Zammit A; Bordoni E; Mioli V; Capobianco P; Martarelli D; Cecchini F; De Jasi A; Capponi E; Panichi N; Castelli F; Concetti M
Minerva Nefrol; 1982; 29(4):215-21. PubMed ID: 7155441
[No Abstract] [Full Text] [Related]
14. [Dopamine 17-beta-hydroxylase in chronic uremic patients under periodic hemodialytic treatment].
Cagossi M; Pigliucci GM; Ruvolo MR; Porcelli G
Chir Patol Sper; 1979 Dec; 27(6):579-89. PubMed ID: 400642
[No Abstract] [Full Text] [Related]
15. [Hemodynamic evaluation of chronic uremic patients undergoing periodical hemodialytic treatment].
Lojacono L; Butti A; Castagneto M; Cagossi M; Salerni B; Pigliucci GM; Alquati P
Chir Patol Sper; 1970 Dec; 18(5):411-33. PubMed ID: 5525552
[No Abstract] [Full Text] [Related]
16. [Gynecomastia in hemodialysis].
Barrientos Guzmán A; Alvarez Grande J; Hernando Avendaño L
Rev Clin Esp; 1970 Aug; 118(4):365-6. PubMed ID: 5486103
[No Abstract] [Full Text] [Related]
17. [Pulmonary diffusion capacity in uremic patients undergoing maintenance hemodialytic treatment].
Casucci G; Marchesi N; Buoncristiani U; Timio M; Sorbini CA
Minerva Nefrol; 1971; 18(3):186-8. PubMed ID: 5115764
[No Abstract] [Full Text] [Related]
18. [Critical considerations on the neurological manifestations during chronic uremia related to the hemodialytic treatment].
Barbera G; Rapisarda LM
Minerva Med; 1970 Nov; 61(90):5134-9. PubMed ID: 5488544
[No Abstract] [Full Text] [Related]
19. [High levels of digoxin encountered in patients with chronic uremia undergoing a periodic hemodialytic treatment and conservative therapy].
Filoramo F; Redaelli B; Pincella G; Sforzini S; Limido D; D'Amico P; Valagussa F
Minerva Nefrol; 1976; 23(5):393-6. PubMed ID: 1018876
[No Abstract] [Full Text] [Related]
20. [HDL-cholesterol in chronic uremia during hemodialytic treatment].
Solinas A; Demelia L; Cogoni G; Porcu A; Civolani P; Usai E; Pitzus F
Minerva Nefrol; 1981; 28(4):455-60. PubMed ID: 7339513
[No Abstract] [Full Text] [Related]
[Next] [New Search]
